These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24829925)

  • 21. Effect of sitagliptin on glycemic control and beta cell function in Japanese patients given basal-supported oral therapy for type 2 diabetes.
    Asai S; Ohta A; Kato H; Sada Y; Nagai Y; Kondo A; Sasaoka T; Tanaka Y
    Endocr J; 2014; 61(12):1213-20. PubMed ID: 25231694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Islet autoimmunity identifies a unique pattern of impaired pancreatic beta-cell function, markedly reduced pancreatic beta cell mass and insulin resistance in clinically diagnosed type 2 diabetes.
    Subauste A; Gianani R; Chang AM; Plunkett C; Pietropaolo SL; Zhang YJ; Barinas-Mitchell E; Kuller LH; Galecki A; Halter JB; Pietropaolo M
    PLoS One; 2014; 9(9):e106537. PubMed ID: 25226365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fasting serum total bile acid levels are associated with insulin sensitivity, islet β-cell function and glucagon levels in response to glucose challenge in patients with type 2 diabetes.
    Wang XH; Xu F; Cheng M; Wang X; Zhang DM; Zhao LH; Cai HL; Huang HY; Chen T; Zhang XL; Wang XQ; Cheng XB; Su JB; Lu Y
    Endocr J; 2020 Nov; 67(11):1107-1117. PubMed ID: 32684527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetic ketoacidosis at the onset of type 1 diabetes is associated with future HbA1c levels.
    Fredheim S; Johannesen J; Johansen A; Lyngsøe L; Rida H; Andersen ML; Lauridsen MH; Hertz B; Birkebæk NH; Olsen B; Mortensen HB; Svensson J;
    Diabetologia; 2013 May; 56(5):995-1003. PubMed ID: 23389397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancreatic Fat is not significantly correlated with β-cell Dysfunction in Patients with new-onset Type 2 Diabetes Mellitus using quantitative Computed Tomography.
    Li YX; Sang YQ; Sun Y; Liu XK; Geng HF; Zha M; Wang B; Teng F; Sun HJ; Wang Y; Qiu QQ; Zang X; Wang Y; Wu TT; Jones PM; Liang J; Xu W
    Int J Med Sci; 2020; 17(12):1673-1682. PubMed ID: 32714070
    [No Abstract]   [Full Text] [Related]  

  • 26. Nationwide survey to compare the prevalence of transient elevation of liver transaminase during treatment of diabetic ketosis or ketoacidosis in new-onset acute and fulminant type 1 diabetes mellitus.
    Takaike H; Uchigata Y; Iwamoto Y; Imagawa A; Iwahashi H; Kanatsuka A; Kawasaki E; Kobayashi T; Shimada A; Shimizu I; Maruyama T; Hanafusa T; Makino H
    Ann Med; 2008; 40(5):395-400. PubMed ID: 18484350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is HOMA-IR a potential screening test for non-alcoholic fatty liver disease in adults with type 2 diabetes?
    Gutierrez-Buey G; Núñez-Córdoba JM; Llavero-Valero M; Gargallo J; Salvador J; Escalada J
    Eur J Intern Med; 2017 Jun; 41():74-78. PubMed ID: 28283346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between β-cell function, metabolic control, and microvascular complications in type 2 diabetes mellitus.
    Zhao L; Ma J; Wang S; Xie Y
    Diabetes Technol Ther; 2015 Jan; 17(1):29-34. PubMed ID: 25574593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term effects on glycaemic control and β-cell preservation of early intensive treatment in patients with newly diagnosed type 2 diabetes: A multicentre randomized trial.
    Chon S; Rhee SY; Ahn KJ; Baik SH; Park Y; Nam MS; Lee KW; Yoo SJ; Koh G; Lee DH; Kim YS; Woo JT;
    Diabetes Obes Metab; 2018 May; 20(5):1121-1130. PubMed ID: 29272062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vildagliptin added to metformin on β-cell function after a euglycemic hyperinsulinemic and hyperglycemic clamp in type 2 diabetes patients.
    Derosa G; Ragonesi PD; Carbone A; Fogari E; Bianchi L; Bonaventura A; Romano D; Cicero AF; Maffioli P
    Diabetes Technol Ther; 2012 Jun; 14(6):475-84. PubMed ID: 22512264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of insulin resistance and β cell function in the development of newly diagnosed type 2 diabetes].
    Chen X; Su M; Wang C; Wu Z; Li S; Ying X; Wei G; Fu C; Jiang Q
    Wei Sheng Yan Jiu; 2015 Nov; 44(6):881-6. PubMed ID: 26738376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Relationship between Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease Measured by Controlled Attenuation Parameter.
    Chon YE; Kim KJ; Jung KS; Kim SU; Park JY; Kim do Y; Ahn SH; Chon CY; Chung JB; Park KH; Bae JC; Han KH
    Yonsei Med J; 2016 Jul; 57(4):885-92. PubMed ID: 27189281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of β-cell dysfunction and insulin resistance correlating obesity with type 2 diabetes: A cross-sectional study.
    Liu J; Wang Y; Hu Y; Leng S; Wang G
    J Diabetes Complications; 2016 Jul; 30(5):898-902. PubMed ID: 27012460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in circulating adiponectin, leptin, glucose and C-peptide in patients with ketosis-prone diabetes.
    Gupta P; Liu Y; Lapointe M; Yotsapon T; Sarat S; Cianflone K
    Diabet Med; 2015 May; 32(5):692-700. PubMed ID: 25407468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of islet function on typing and prognosis of new-onset diabetes after intensive insulin therapy.
    Fan H; Pan Q; Zhang P; Liu J; Xu Y; Yang X
    Med Sci Monit; 2013 Sep; 19():787-93. PubMed ID: 24056309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ketosis-prone type 2 diabetes: effect of hyperglycemia on beta-cell function and skeletal muscle insulin signaling.
    Umpierrez GE; Smiley D; Gosmanov A; Thomason D
    Endocr Pract; 2007; 13(3):283-90. PubMed ID: 17599861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect and mechanism of transient continuous subcutaneous insulin infusion therapy on beta cell function, insulin resistance and vascular endothelial injury in newly diagnosed type 2 diabetes].
    Liu SP; Mo H; Liu BL; Tang WL; Deng XG; Su X; Yao L; Lin J; Feng Q; Peng J; Zhou ZG; Li YJ
    Zhonghua Nei Ke Za Zhi; 2010 May; 49(5):405-9. PubMed ID: 20646415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Soft drink ketosis].
    Yamada K
    Nihon Rinsho; 2006 Sep; Suppl 3():90-3. PubMed ID: 17022507
    [No Abstract]   [Full Text] [Related]  

  • 40. Dipeptidyl-Peptidase-IV Inhibitors, Imigliptin and Alogliptin, Improve Beta-Cell Function in Type 2 Diabetes.
    Liu X; Liu Y; Liu H; Li H; Yang J; Hu P; Xiao X; Liu D
    Front Endocrinol (Lausanne); 2021; 12():694390. PubMed ID: 34616361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.